Suppression of cutaneous inflammation by intradermal gene delivery

Gene Therapy

Volumn 9, Issue 1, 2002, Pages 38-45

  Rao, K V N ^a   He, Y X ^a   Ramaswamy, K ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Cytokines; ICAM 1; Inflammation; Neutrophils; Schistosoma mansoni; Skin

Indexed keywords

ANTIINFLAMMATORY AGENT; COMPLEMENTARY DNA; INTERCELLULAR ADHESION MOLECULE 1; PROTEIN SM16; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DERMIS; DOWN REGULATION; DRUG EFFECT; EPIDERMIS; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENETIC TRANSFECTION; IN VIVO STUDY; LYMPH NODE; MITOGENESIS; MOLECULAR CLONING; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SKIN CELL; SKIN EDEMA; SKIN INFLAMMATION;

ANIMALIA; SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 0036172638     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301622     Document Type: Article

References (31)

1. The global status of Schistosomiasis and its control
2. ICAM-1 and iNOS expression increased in the skin of mice after vaccination with gamma-irradiated cercariae of Schistosoma mansoni
3. Schistosoma mansoni schistosomula reduce E-selectin and VCAM-1 expression in TNF-alpha stimulated lung microvascular endothelial cells by interfering with NF-xB pathway
4. Schistosoma mansoni activates host microvascular endothelial cells to acquire an anti-inflammatory phenotype
5. Secretion of an anti-inflammatory, immunomodulatory factor by Schistosomulae of Schistosoma mansoni
6. Modulation of IL-1α, IL-1β and IL-1RA production in human keratinocytes by schistosomulae of Schistosoma mansoni
7. Immune evasion by Schistosoma mansoni: Characterization of Sm16.8 an anti-inflammatory protein produced by the skin stage schistosomulum
8. Cloning and expression of a gene encoding Sm16, an anti-inflammatory protein from Schistosoma mansoni
9. Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy
10. Expression of factor VII by muscle cells in vitro and in vivo following direct gene transfer: Modelling gene therapy for haemophilia
11. Expression of biologically active human insulin-like growth factor-I following intramuscular injection of a formulated plasmid in rats
12. Cytokine gene expression in epidermis with biological effects following injection of naked DNA
13. Induction of keratinocyte proliferation and lymphocytic infiltration by in vivo introduction of the IL-6 gene into keratinocytes and possibility of keratinocyte gene therapy for inflammatory skin diseases using IL-6 mutant genes
14. Keratinocyte gene therapy for systemic diseases
15. Therapeutic application of T cell receptor mimic peptides or cDNA in the treatment of T cell-mediated skin diseases
16. Interactions of leukocyte integrins with intercellular adhesion molecule 1 in the production of inflammatory vascular injury in vivo. The Shwartzman reaction revisited
17. Uptake of exogenous DNA via the skin
18. A direct in vivo approach for skin gene therapy
19. Expression of naked DNA in human, pig, and mouse skin
20. Topical gene delivery to murine skin
21. Stage-specific expression of a Schistosoma mansoni polypeptide similar to the vertebrate regulatory protein stathmin
22. Schistosoma mansoni: Quantification of skin penetration and early migration by differential external radioassay and autoradiography
23. Isotype responses to candidate vaccine antigens in protective sera obtained from mice vaccinated with irradiated cercariae of Schistosoma mansoni
24. Parasite features impeding malaria immunity: Antigenic diversity, antigenic variation and poor immunogenicity
25. Gene therapy for skin diseases
26. Nonviral transfer of genes to pig primary keratinocytes. Induction of angiogenesis by composite grafts of modified keratinocytes overexpressing VEGF driven by a keratin promoter
27. Analysis of reporter gene expression in ovine dermis and afferent lymph dendritic cells in vitro and in vivo
28. DNA-based immunization by in vivo transfection of dendritic cells
29. Antigen-bearing Langerhans cells in skin draining lymph nodes: Phenotype and kinetics of migration
30. Cell-mediated DNA transport between distant inflammatory sites following intradermal DNA immunization in the presence of adjuvant
31. Immunization through dermal delivery of protein-encoding DNA: A role for migratory dendritic cells